Adipose tissue inflammation. Part 1. Morphological and functional manifestations
https://doi.org/10.14341/probl200955444-49
Abstract
The review describes a new pathomorphological phenomenon: adipose tissue inflammation (ATI) that develops in obesity and is characterized by cell infiltration, fibrosis, microcirculatory changes, a shift in adipokine secretion and adipose tissue metabolism, as well as blood accumulation of nonspecific inflammatory markers, such as C-reactive protein, fibrinogen, leukocytes, the level of which reflects the degree of the process. The changes in adipokine secretion and shifts in fat and carbohydrate metabolism, which are typical of ATI, favor the development of atherosclerosis, essential hypertension, type 2 diabetes, and the metabolic syndrome. ATI shows up as a connecting link between these diseases and obesity. The definition of obesity as a chronic inflammatory disease is justified.
References
1. Шварц В. // Пробл. эндокринол. - 2009. - № 1. - С. 38-44.
2. Babior B. M. // Am. J. Med. - 2000. - Vol. 109. - P. 33-44.
3. Blankenburg S., Barbaux S., Tiret L. // Atherosclerosis. - 2003. - Vol. 170. - P. 191-203.
4. Bosello S., Santoliquido A., Zoli A. et al. // Clin. Rheumatol. - 2008. - Vol. 27. - P. 833-839.
5. Bouloumie A., Casteilla L., Lafontan M. // Arterioscler. Thromb. Vasc. Biol. - 2008. - Vol. 28. - P. 1211-1213.
6. Bourloier V., Zakaroff-Girard A., Miranville A. et al. // Circulation. - 2008. - Vol. 117. - P. 806-815.
7. Bouskela E., Kraemer de Aguiar L. G., Novoit P. et al. // Bull. Acad. Natl. Med. - 2007. - Vol. 191, N 3. - P. 475-492.
8. Cancello R., Henegar C., Viguerie N. et al. // Diabetes. - 2005. - Vol. 54. - P. 2277-2286.
9. Cancello R., Clement K. // Br. J. Obstet. Gynecol. - 2006. - Vol. 113. - P. 1141-1147.
10. Cancello R., Tordjman J., Poitou C. et al. // Diabetes. - 2006. - Vol. 55. - P. 1554-1561.
11. Cheng K. H., Chu C. S., Lee K. T. et al. // Int. J. Obes. (Lond.). - 2008. - Vol. 32. - P. 268-274.
12. Cinti S. et al. // J. Lipid Res. - 2005. - Vol. 46. - P. 2347-2355.
13. Clement K., Viguerie N., Poitou C. et al. // FASEB J. - 2004. - Vol. 18. - P. 1657-1669.
14. Constant V. A., Gagnon A., Yarmo M. et al. // Metabolism. - 2008. - Vol. 57. - P. 465-472.
15. Creager M. A., Luscher T. F., Cosentino F., Beckman J. A. // Circulation. - 2003. - Vol. 108. - P. 1527-1532.
16. Curat C. A., Wegner V., Sengenes C. et al. // Diabetologia. - 2006. - Vol. 49. - P. 1894-1903.
17. Elgazar-Carmon V., Rudich A., Hadad N., Levy R. // J. Lipid Res. - 2008.
18. Engeli S., Feldpausch M., Gorzelniak K. et al. // Diabetes. - 2003. - Vol. 52. - P. 942-947.
19. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. // Endocr. Rev. - 2002. - Vol. 23. - P. 599-622.
20. Fantuzzi G., Faggioni R. // J. Leukocyte Biol. - 2000. - Vol. 68. - P. 437-446.
21. Fantuzzi G., Mazzone T. // Arterioscler. Thromb. Vasc. Biol. - 2007. - Vol. 27. - P. 996-1003.
22. Fernandez-Real J. M., Ricart W. // Endocr. Rev. - 2003. - Vol. 24. - P. 278-301.
23. Fox C. S. et al. // Circulation. - 2007. - Vol. 116. - P. 39-48.
24. Furuhashi M., Fucho R., Gorgun C. Z. et al. // J. Clin. Invest. - 2008. - Vol. 118. - P. 2640-2650.
25. Griendling K. K., Sorescu D., Ushio-Fukai M. // Circ. Res. - 2000. - Vol. 86. - P. 494-501.
26. Griffin M. E. et al. // Diabetes. - 1999. - Vol. 48. - P. 1270-1274.
27. Hatoum O. A., Heidemann J., Bnion D. G. // Ann. N. Y. Acad. Sci. - 2006. - Vol. 1072. - P. 78-97.
28. Hattori Y., Nakano Y., Hattori S. et al. // FEBS J. - 2008. - Vol. 582. - P. 1719-1724.
29. Henegar C., Tordjmin J., Achard V. et al. // Genome Biol. - 2008. - Vol. 9. - P. 14-27.
30. Hess K., Marx N. // Diabetes Stoffw. Herz. - 2007. - Vol. 16. - P. 433-440.
31. Hoch M., Eberle A. N., Peterli R. et al. // Cytokine. - 2008. - Vol. 41. - P. 29-37.
32. Huber J., Kiefer F. W., Zeyda M. et al. // J. Clin. Endocrinol. Metab. - 2008. - Vol. 93. - P. 3215-3221.
33. Itani S. I., Ruderman N. B., Schmieder F. et al. // Diabetes. - 2002. - Vol. 51. - P. 2005-2011.
34. Kampf C., Bodin B., Kallskog O. et al. // Diabetes. - 2005. - Vol. 54. - P. 2620-2627.
35. Kanda H., Tateya S., Tamori Y. et al. // J. Clin. Invest. - 2006. - Vol. 118, N 4. - P. 1494-1505.
36. Kang K., Reilly S. M., Karabacak V. et al. //Cell Metab. - 2008. - Vol. 7. - P. 485-495.
37. Kintscher U., Hartge M., Hess K. et al. // Artherioscler. Thromb. Vasc. Biol. - 2008. - Vol. 28. - P. 1304-1310.
38. Kita T., Kume N., Minami M. et al. // Ann. N. Y. Acad. Sci. - 2001. - Vol. 947. - P. 199-206.
39. Kumar V., Fausto N., Abbas A. // Robbins Cotran: Pathologic Basis of Diseae. - 7-th Ed. - Philadelphia, 2005. - P. 47-86.
40. Kunsch C., Medford R. M. // Circ. Res. - 1999. - Vol. 85. - P. 753-766.
41. Lumeng C. N., Bodzin J. L., Saltiel A. R. // J. Clin. Invest. - 2007. - Vol. 117. - P. 175-184.
42. Matsuoka H. // Diabet. Res. Clin. Pract. - 2001. - Vol. 54. - Suppl. - P. S65-S72.
43. McIntyre M., Bohr D. F., Dominiczak A. F. // Hypertension. - 1999. - Vol. 34. - P. 539-545.
44. Miller M. A., Cappuccio F. P. // Int. J. Obes. (Lond.). - 2006. - Vol. 30. - P. 1176-1182.
45. Miranville A., Sengenes C. et al. // Diabetes. - 2004. - Vol. 53. - P. 1285-1292.
46. Murano I., Barbatelli G., Parisani V. et al. // J. Lipid Res. - 2008. - Vol. 49. - P. 1562-1568.
47. Naya M., Tsukamoto T., Morita K. et al. // Hypertens. Res. - 2007. - Vol. 30. - P. 541-548.
48. Nishimura S., Manabe I., Nagasaki M. et al. // J. Clin. Invest. - 2008. - Vol. 118. - P. 710-721.
49. Nisoli E., Clementi E., Carruba M. O., Moncada S. // Circ. Res. - 2007. - Vol. 100. - P. 795-806.
50. Ouchi N.,Kihara S., Arita Y. et al. // Circulation. - 2006. - Vol. 120. - P. 1296-1301.
51. Pang C., Gao Z., Yin J. et al. // Am. J. Physiol. Endocrinol. Metab. - 2008.
52. Plutzky J. // Am. J. Cardiol. - 2001. - Vol. 88. - P. 10-15.
53. Ricard-Blum S., Bresson-Hadni S., Vuitton D. A. et al. // Hepatology. - 1992. - Vol. 15. - P. 599-602.
54. Sbarbati A., Osculati F., Silvagni D. et al. // Pediatics. - 2006. - Vol. 117. - P. 220-223.
55. Sell H., Dietze-Schroeder D., Eckel J. // Trends Endocrinol. Metab. - 2006. - Vol. 17. - P. 416-422.
56. Simonsen L., Enevoldsen L. H., Bulow J. // Clin. Physiol. Funct. Imag. - 2003. - Vol. 23. - P. 320-323.
57. Steinberg H. O., Tarshoby M., Monestel R. et al. // J. Clin. Invest. - 1997. - Vol. 100. - P. 1230-1239.
58. Stiestra R., Duval C., Keshtkar S. et al. // J. Biol. Chem. - 2008. - Vol. 283. - P. 22620-22627.
59. Suganami T., Nishida J., Ogawa Y. // Arterioscler. Thromb. Vasc. Biol. - 2005. - Vol. 25. - P. 2062-2068.
60. Summers L. K., Samra J. S., Frayn K. N. // Atherosclerosis. - 1999. - Vol. 147. - P. 11-15.
61. Taniyama Y., Griendling K. K. // Hypertension. - 2003. - Vol. 42. - P. 1075-1081.
62. Toyoda T., Kamei Y., Kato H. et al. // Obesity. - 2008. - Vol. 16. - P. 1199-1207.
63. Trayhurn P., Wang B., Wood I. S. // Br. J. Nutr. - 2008. - Vol. 96. - P. 1-9.
64. Weisberg S. P., McCann D., Desai M. et al. // J. Clin. Invest. - 2003. - Vol. 112. - P. 1796-1808.
65. Zhu J., Yong W., Wu X. et al. // Biochem. Biophys. Res. Commun. - 2008. - Vol. 369. - P. 471-477.
Review
For citations:
Shvarts V. Adipose tissue inflammation. Part 1. Morphological and functional manifestations. Problems of Endocrinology. 2009;55(4):44-49. (In Russ.) https://doi.org/10.14341/probl200955444-49

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).